NRGene and Kayagene Introduce the First Fully-Phased Cannabis Genome

February 13, 2019

In a breakthrough research, NRGene, a leading agricultural genomics company based in Israel, and Kayagene, a California-based cannabis breeding company, have announced the completion of the first fully-phased cannabis genome using NRGene's DeNovoMAGIC technology.

"We have now only begun to realize the potential in cannabis, as over 99% of its genetic diversity was never studied," said Dr. Gil Ronen, President of NRGene. "Our fully-phased genomes reveal the hidden secrets of diverse cannabis strains and enable us to efficiently implement them for future treatments of multiple human medical conditions," he added.

For more details, read the news release from NRGene.